advertisement

WGA Rescources

11.8 Neuroprotection (22)

Showing records 1 to 22

Display all abstracts in classification 11.8 Neuroprotection

Search within classification 11.8 Neuroprotection
53832 Potassium ion channels in retinal ganglion cells (Review)
Zhong YS; Wang J; Liu WM; Zhu YH
Molecular medicine reports 2013; 8: 311-319
53841 Central nervous system changes in glaucoma
Yücel Y
Journal of Glaucoma 2013; 22: S24-5
53786 The potential of stem cell research for the treatment of neuronal damage in glaucoma
Karl MO
Cell and Tissue Research 2013; 353: 311-325
53847 Cell-based therapies for retinal degenerative diseases: a thousand strategies
Lewallen M; Xie T
Journal of Glaucoma 2013; 22: S42-5
53938 The role of Müller glia and microglia in glaucoma
Seitz R; Ohlmann A; Tamm ER
Cell and Tissue Research 2013; 353: 339-345
53698 Reversible reactivity by optic nerve astrocytes
Sun D; Qu J; Jakobs TC
GLIA 2013; 61: 1218-1235
53708 Idebenone prevents human optic nerve head astrocytes from oxidative stress, apoptosis, and senescence by stabilizing BAX/Bcl-2 ratio
Kernt M; Arend N; Buerger A; Mann T; Haritoglou C; Ulbig MW; Kampik A; Hirneiss C
Journal of Glaucoma 2013; 22: 404-412
53828 Melanopsin-expressing retinal ganglion cell loss and behavioral analysis in the Thy1-CFP-DBA/2J mouse model of glaucoma
Zhang Q; Vuong H; Huang X; Wang Y; Brecha NC; Pu M; Gao J
Science China Life Sciences 2013; 56: 720-730
53975 Brimonidine protects against loss of Thy-1 promoter activation following optic nerve crush
Dai Y; Lindsey JD; Duong-Polk KX; Chindasub P; Leung CK; Weinreb RN
BMC Ophthalmology 2013; 13: 26
53923 The challenges of axon survival: Introduction to the special issue on axonal degeneration
Coleman MP
Experimental Neurology 2013; 246: 1-5
53919 Canadian Journal of Ophthalmology Lecture: Translational research advances in glaucoma neuroprotection
Tsai JC
Canadian Journal of Ophthalmology 2013; 48: 141-145
53933 Nerve growth factor: basic studies and possible therapeutic applications
Manni L; Rocco ML; Bianchi P; Soligo M; Guaragna M; Barbaro SP; Aloe L
Growth Factors 2013; 31: 115-122
53738 Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate
Santos-Carvalho A; Elvas F; Alvaro AR; Ambrósio AF; Cavadas C
Cell Death and Disease 2013; 4: e636
53740 Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic
Mi S; Blake Pepinsky R; Cadavid D
CNS Drugs 2013; 27: 493-503
53743 The cell stress machinery and retinal degeneration
Athanasiou D; Aguilà M; Bevilacqua D; Novoselov SS; Parfitt DA; Cheetham ME
FEBS Letters 2013; 587: 2008-2017
53857 A modified chronic ocular hypertension rat model for retinal ganglion cell neuroprotection
Zhong L
Frontiers of medicine 2013; 7: 367-377
53804 Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death
Himori N; Yamamoto K; Maruyama K; Ryu M; Taguchi K; Yamamoto M; Nakazawa T
Journal of Neurochemistry 2013; 127: 669-680
53792 Status and perspectives of neuroprotective therapies in glaucoma: The European Glaucoma Society White Paper
Tamm ER; Schmetterer L; Grehn F
Cell and Tissue Research 2013; 353: 347-354
53686 Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity
Bai N; Hayashi H; Aida T; Namekata K; Harada T; Mishina M; Tanaka K
Molecular brain 2013; 6: 22
54051 Research advances on the usage of traditional Chinese medicine for neuroprotection in glaucoma
Mi XS; Zhong JX; Chang RC; So KF
Journal of integrative medicine 2013; 11: 233-240
53472 Dynamic mobilization of PGC-1α mediates mitochondrial biogenesis for the protection of RGC-5 cells by resveratrol during serum deprivation
Chen S; Fan Q; Li A; Liao D; Ge J; Laties AM; Zhang X
Apoptosis 2013; 18: 786-799
54025 Adeno-associated virus-mediated expression of growth-associated protein-43 aggravates retinal ganglion cell death in experimental chronic glaucomatous injury
Huang C; Cen LP; Liu L; Leaver SG; Harvey AR; Cui Q; Pang CP; Zhang M
Molecular Vision 2013; 19: 1422-1432

Issue 15-2

Change Issue


advertisement

Oculus